Login / Signup

Vonoprazan and amoxicillin dual therapy for 14 days as the first-line treatment of Helicobacter pylori infection: A non-inferiority, randomized clinical trial.

Yi HuXiang-Hua HuangBo ZhouMeng-Lan LiuYe-Fei LiuTao YuPing SunBin-Bin TanYang HuFei ChengXiao-Lin PanJun-Bo HongXu ShuYin ZhuNong Hua Lu
Published in: Helicobacter (2024)
Vonoprazan with b.i.d. amoxicillin for 14 days provided similar satisfactory efficacy with vonoprazan-containing quadruple therapy as a first-line H. pylori treatment in China.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • endoscopic submucosal dissection
  • stem cells
  • clinical trial
  • combination therapy
  • gastroesophageal reflux disease